EQS-News: NeuroOne(R) Announces Virtual Investor Webinar on October 7, 2025 at 8:30 a.m. EST

EDEN PRAIRIE, MINN. - September 29, 2025 (NEWMEDIAWIRE) - NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders, announced today that it will hold a virtual roadshow webinar to discuss its business operations, recent FDA clearance and corporate updates.

The webcast will be accompanied by a presentation and followed by a question-and-answer session, which can be accessed via the webcast link or dial-in numbers below.

Date: Tuesday, October 7, 2025
Time: 8:30 a.m. Eastern Standard Time
U.S. Dial-In (Toll Free): 888-506-0062
International Dial-In: 973-528-0011
Access code: 619723
Webcast Link: NMTC Virtual Webinar Link

Please join at least five minutes before the start of the call to ensure timely participation.

A playback of the call will be available through October 21, 2025. To listen, please call 877-481-4010 within the United States or 919-882-2331 when calling internationally, using replay passcode 53045.

About NeuroOne

NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) is developing and commercializing minimally invasive and hi-definition solutions for EEG recording, monitoring, ablation, drug delivery and stimulation solutions for patients suffering from epilepsy, Parkinson’s disease, dystonia, essential tremors, chronic pain due to failed back surgeries and other related neurological disorders that may improve patient outcomes and reduce procedural costs. The Company may also pursue applications for other areas such as depression, mood disorders, pain, incontinence, high blood pressure, and artificial intelligence. For more information, visit nmtc1.com.

IR Contact

MZ Group - MZ North America
NMTC@mzgroup.us